You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
|
---|---|
Published in |
BMC Cancer, December 2009
|
DOI | 10.1186/1471-2407-9-433 |
Pubmed ID | |
Authors |
Jessica N McAlpine, Kimberly C Wiegand, Russell Vang, Brigitte M Ronnett, Anna Adamiak, Martin Köbel, Steve E Kalloger, Kenneth D Swenerton, David G Huntsman, C Blake Gilks, Dianne M Miller |
Abstract |
The response rate of ovarian mucinous carcinomas to paclitaxel/carboplatin is low, prompting interest in targeted molecular therapies. We investigated HER2 expression and amplification, and the potential for trastuzumab therapy in this histologic subtype of ovarian cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 1% |
United Kingdom | 1 | 1% |
Canada | 1 | 1% |
Spain | 1 | 1% |
United States | 1 | 1% |
Unknown | 73 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 23% |
Student > Postgraduate | 9 | 12% |
Other | 8 | 10% |
Student > Ph. D. Student | 6 | 8% |
Student > Master | 6 | 8% |
Other | 16 | 21% |
Unknown | 15 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 37% |
Agricultural and Biological Sciences | 16 | 21% |
Biochemistry, Genetics and Molecular Biology | 7 | 9% |
Nursing and Health Professions | 1 | 1% |
Psychology | 1 | 1% |
Other | 3 | 4% |
Unknown | 21 | 27% |